Tectonic Therapeutic (TECX) Research & Development (2017 - 2026)

Tectonic Therapeutic (TECX) has 10 years of Research & Development data on file, last reported at $20.9 million in Q1 2026.

• On a quarterly basis, Research & Development rose 60.1% year-over-year to $20.9 million in Q1 2026; TTM through Mar 2026 was $71.3 million, a 63.65% increase from a year earlier, with the FY2025 full-year figure at $63.5 million, up 53.49% from the prior year.
• Research & Development for Q1 2026 stood at $20.9 million, up from $16.3 million in the prior quarter.
• Over the last five years, Research & Development for TECX reached as high as $20.9 million in Q1 2026 and fell as low as $7.1 million in Q2 2024.
• Historically, Research & Development has averaged $14.1 million across 5 years, with a median of $15.9 million in 2022.
• Across the five-year window, Research & Development sank 60.35% in 2023 and surged 142.93% in 2025, its largest moves.
• Year by year, Research & Development stood at $18.1 million in 2022, then sank by 60.35% to $7.2 million in 2023, then climbed by 27.31% to $9.2 million in 2024, then jumped by 78.47% to $16.3 million in 2025, then grew by 27.72% to $20.9 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $20.9 million in Q1 2026, $16.3 million in Q4 2025, and $16.9 million in Q3 2025.